BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7462415)

  • 21. The development of an M antibody capture ELISA for rubella IgM.
    Bellamy K; Rousseau SA; Gardner PS
    J Virol Methods; 1986 Nov; 14(3-4):243-51. PubMed ID: 3539958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with a live RA 27/3 strain rubella vaccine (Rudivax), a follow-up study.
    Suni JI; Meurman O; Hirvonen P; Vaheri A
    Vaccine; 1984 Dec; 2(4):281-3. PubMed ID: 6531969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing for rubella-specific IgG antibody in urine.
    Terada K; Niizuma T; Kataoka N; Niitani Y
    Pediatr Infect Dis J; 2000 Feb; 19(2):104-8. PubMed ID: 10693994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibody response to live rubella vaccination and its clinical meanings].
    Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. History of RA27/3 rubella vaccine.
    Plotkin SA; Buser F
    Rev Infect Dis; 1985; 7 Suppl 1():S77-8. PubMed ID: 3890107
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical evaluation of a rubella passive hemagglutination test system.
    Kilgore JM
    J Med Virol; 1979; 3(3):231-6. PubMed ID: 479859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment].
    Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M
    Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies.
    Budzko DB; Jelinek DF; Wilcke BW
    J Clin Microbiol; 1981 May; 13(5):818-23. PubMed ID: 7240394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of albumin on rubella virus hemagglutination and the hemagglutination-inhibition test.
    Campbell JB; Grunberger T; Ellins ML
    Can J Microbiol; 1975 Aug; 21(8):1172-7. PubMed ID: 240497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Problems of rubella prevention: vaccination of 51 fertile young women with the Wister Ra 27/3 virus strain].
    Russo F; Piro E; Frugiuele PL; Buffone E; Palma B; Greco LM
    Ann Sclavo; 1980; 22(1):57-62. PubMed ID: 7247485
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the hemagglutination inhibition test and an indirect fluorescent-antibody test for detection of antibody to rubella virus in human sera.
    Cremer NE; Hagens SJ; Cossen C
    J Clin Microbiol; 1980 Jun; 11(6):746-7. PubMed ID: 7000822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunoglobulin M response to rubella vaccine in young adult women.
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Haslehurst J
    J Hyg (Lond); 1984 Jun; 92(3):277-83. PubMed ID: 6376624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
    Müller G; Baumann H
    Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rubella precipitin response in natural infection and in vaccination.
    Paul NR; Rhodes AJ; Campbell JB; Labzoffsky NA
    Arch Gesamte Virusforsch; 1974; 45(4):335-51. PubMed ID: 4216341
    [No Abstract]   [Full Text] [Related]  

  • 39. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.
    Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F
    J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.